# Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment

> **NCT06914661** · — · ENROLLING_BY_INVITATION · sponsor: **The First Hospital of Jilin University** · enrollment: 200 (estimated)

## Conditions studied

- Breast Cancer Metastatic
- Efficacy and Safety

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06914661
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-05-25
- **Primary completion:** 2025-08-30
- **Final completion:** 2025-10-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914661, "Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06914661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*